Literature DB >> 25331014

The relationship between economic characteristics and health-related quality of life in newly diagnosed cancer patients in Southeast Asia: results from an observational study.

Merel Kimman1, Stephen Jan, Helen Monaghan, Mark Woodward.   

Abstract

PURPOSE: We investigate whether cancer patients' economic characteristics are independent determinants of health-related quality of life (HRQoL) in low- and middle-income settings to identify priorities for health policy and research.
METHODS: A cross-sectional survey of 9,513 cancer patients from Southeast Asia provided data on demographics, economic status and HRQoL. HRQoL was measured using the EORTC QLQ-C30 and EQ-5D. Information on cancer site and stage was collected using the patients' medical records. Multiple linear regression analysis estimated the relative impact of economic characteristics (i.e. health insurance, employment status, household income and economic hardship) on HRQoL.
RESULTS: All economic characteristics were significant independent determinants of HRQoL, when we controlled for demographic and clinical characteristics. Economic hardship was found to be most important. The adjusted mean differences in HRQoL scores between patients who had experienced economic hardship in the year before diagnosis compared to patients who did not were -5.6, -6.7, -7.3 and -0.06, respectively, for global health, physical function, emotional function and the EQ-5D index (all p values <0.001). Subgroup analyses showed that this significant result for economic hardship as a predictor of poor HRQoL was consistent across all age groups, for males and females, and across all levels of education.
CONCLUSIONS: Living in poor economic circumstances before a cancer diagnosis is associated with greatly impaired HRQoL after diagnosis. There is wide scope for research on innovative interventions that provide low-cost and targeted support aimed to improve health outcomes of disadvantaged cancer patients in low- and middle-income settings.

Entities:  

Mesh:

Year:  2014        PMID: 25331014     DOI: 10.1007/s11136-014-0828-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  34 in total

1.  Moving cancer up the global health agenda.

Authors: 
Journal:  Lancet       Date:  2010-06-12       Impact factor: 79.321

2.  A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.

Authors:  Chantal Quinten; Francesca Martinelli; Corneel Coens; Mirjam A G Sprangers; Jolie Ringash; Carolyn Gotay; Kristin Bjordal; Eva Greimel; Bryce B Reeve; John Maringwa; Divine E Ediebah; Efstathios Zikos; Madeleine T King; David Osoba; Martin J Taphoorn; Henning Flechtner; Joseph Schmucker-Von Koch; Joachim Weis; Andrew Bottomley
Journal:  Cancer       Date:  2013-10-11       Impact factor: 6.860

3.  Health-financing reforms in southeast Asia: challenges in achieving universal coverage.

Authors:  Viroj Tangcharoensathien; Walaiporn Patcharanarumol; Por Ir; Syed Mohamed Aljunid; Ali Ghufron Mukti; Kongsap Akkhavong; Eduardo Banzon; Dang Boi Huong; Hasbullah Thabrany; Anne Mills
Journal:  Lancet       Date:  2011-01-25       Impact factor: 79.321

4.  Changes in health-related quality of life by occupational status among women diagnosed with breast cancer--a population-based cohort study.

Authors:  Marie Høyer Lundh; Claudia Lampic; Karin Nordin; Johan Ahlgren; Leif Bergkvist; Mats Lambe; Anders Berglund; Birgitta Johansson
Journal:  Psychooncology       Date:  2013-04-14       Impact factor: 3.894

5.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

Review 6.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

7.  The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry.

Authors:  P A J Vissers; M S Y Thong; F Pouwer; M M J Zanders; J W W Coebergh; L V van de Poll-Franse
Journal:  J Cancer Surviv       Date:  2013-08-06       Impact factor: 4.442

Review 8.  Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review.

Authors:  Saskia F A Duijts; Martine P van Egmond; Evelien Spelten; Peter van Muijen; Johannes R Anema; Allard J van der Beek
Journal:  Psychooncology       Date:  2013-12-23       Impact factor: 3.894

9.  Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study.

Authors:  Karin Jordan; Irina Proskorovsky; Philip Lewis; Jack Ishak; Krista Payne; Noreen Lordan; Charalampia Kyriakou; Cathy D Williams; Sarah Peters; Faith E Davies
Journal:  Support Care Cancer       Date:  2014-02       Impact factor: 3.603

10.  Clinical correlates of health preference and generic health-related quality of life in patients with colorectal neoplasms.

Authors:  Carlos K H Wong; Cindy L K Lam; Jensen T C Poon; Dora L W Kwong
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more
  8 in total

1.  Health-related quality of life among Indigenous Australians diagnosed with cancer.

Authors:  G Garvey; J Cunningham; V Yf He; M Janda; P Baade; S Sabesan; J H Martin; M Fay; J Adams; S Kondalsamy-Chennakesavan; P C Valery
Journal:  Qual Life Res       Date:  2016-02-01       Impact factor: 4.147

2.  The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.

Authors:  Katja Mehlis; Julian Witte; Bastian Surmann; Matthias Kudlich; Leonidas Apostolidis; Jürgen Walther; Dirk Jäger; Wolfgang Greiner; Eva C Winkler
Journal:  BMC Cancer       Date:  2020-06-05       Impact factor: 4.430

3.  Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study.

Authors:  Melissa S Y Thong; Daniela Doege; Linda Weißer; Lena Koch-Gallenkamp; Heike Bertram; Andrea Eberle; Bernd Holleczek; Alice Nennecke; Annika Waldmann; Sylke Ruth Zeissig; Ron Pritzkuleit; Michael Schlander; Hermann Brenner; Volker Arndt
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-13       Impact factor: 4.553

4.  Quality of Life and Its Associated Factors Among Cancer Patients Receiving Chemotherapy at Oncology Hospitals in Vietnam After the Third Wave of the COVID-19 Pandemic.

Authors:  Hanh T H Nguyen; Khanh Linh Duong; Son T Nguyen; Quy Trinh; Hao T L Hoang; Toan Q Phung; Hsiang-Wen Lin; Huong T L Nguyen
Journal:  Cancer Manag Res       Date:  2022-08-11       Impact factor: 3.602

5.  Trajectories of Health-related quality of life in patients with Advanced Cancer during the Last Year of Life: findings from the COMPASS study.

Authors:  Jonathan Lee; Mahham Shafiq; Rahul Malhotra; Semra Ozdemir; Irene Teo; Chetna Malhotra
Journal:  BMC Palliat Care       Date:  2022-10-14       Impact factor: 3.113

6.  Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries.

Authors:  Merel Kimman; Stephen Jan; Cheng Har Yip; Hasbullah Thabrany; Sanne A Peters; Nirmala Bhoo-Pathy; Mark Woodward
Journal:  BMC Med       Date:  2015-08-18       Impact factor: 8.775

Review 7.  Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer.

Authors:  Erik F Blom; Kevin Ten Haaf; Harry J de Koning
Journal:  Pharmacoeconomics       Date:  2020-11       Impact factor: 4.981

8.  A Systematic Literature Review of Health Utility Values in Breast Cancer.

Authors:  Manraj N Kaur; Jiajun Yan; Anne F Klassen; Justin P David; Dilshan Pieris; Manraj Sharma; Louise Bordeleau; Feng Xie
Journal:  Med Decis Making       Date:  2022-01-18       Impact factor: 2.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.